Cagrilintide is a long-acting amylin analogue, whilst retatrutide is a novel triple receptor agonist targeting GLP-1, GIP, and glucagon pathways
How will Cagri-Sema stack up against Tirzepatide and later Retatrutide #obesity #weightloss #T2D novonordisk.com/content/dam/nn How will Cagri-Sema stack up against Tirzepatide and later Retatrutide #obesity #weightloss #T2D novonordisk.com/content/dam/nn I feel like the question is, does amylin agonism or glucagon agonism produce better cardiometabolic, renal and hepatic outcomes
Retatrutide is a newer triple-receptor agonist that hits GLP-1, GIP, and glucagon receptors at once, producing fat-loss results that beat anything that came before it
These parameters are illustrated schematically in Figure 32 where the volume of the beakers into which the drugs diffuse represents the volume of distribution, and the size of the outflow drain in Figures 32B and 32D represents the clearance
Log in ABC (Akkermansia BPC Complex) InfiniWell 60 capsules $N/A (MSRP) Create account for pricing Already have an account
#ObesityCare #GLP1 #Amylin #CagriSema #MetabolicHealth #InnovationInMedicine Interesting point from a nerd who follows this closely Cagrisema wont launch in the flex pen
